Walgreens Boots Alliance (NASDAQ:WBA) Announces Quarterly Earnings Results, Beats Expectations By $0.10 EPS
Walgreens Boots Alliance (NASDAQ:WBA) reported quarterly earnings of $0.63 EPS, exceeding expectations of $0.53 by $0.10. The company generated revenue of $38.59 billion, surpassing the forecast of $37.90 billion, and saw a 4.1% increase compared to the previous year. Despite a negative net margin of 5.87%, it achieved a return on equity of 17.61%. Analysts have mixed ratings on the stock, with an average rating of "Hold" and a consensus price target of $10.59.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) announced its quarterly earnings data on Tuesday. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.53 by $0.10, Zacks reports. The firm had revenue of $38.59 billion for the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. Walgreens Boots Alliance's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.20 earnings per share.
Walgreens Boots Alliance Trading Up 0.3 %
- MarketBeat Week in Review – 03/10 - 03/14
Shares of NASDAQ:WBA opened at $10.71 on Tuesday. Walgreens Boots Alliance has a twelve month low of $8.08 and a twelve month high of $19.48. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The firm has a market cap of $9.26 billion, a P/E ratio of -1.05, a P/E/G ratio of 1.31 and a beta of 0.67. The company has a 50 day moving average of $10.74 and a 200-day moving average of $10.00.
Wall Street Analyst Weigh In
WBA has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft cut Walgreens Boots Alliance from a "hold" rating to a "sell" rating and reduced their price objective for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Royal Bank of Canada lifted their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a "sector perform" rating in a report on Wednesday, January 15th. Wolfe Research raised shares of Walgreens Boots Alliance to a "hold" rating in a report on Monday, February 24th. Evercore ISI upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Finally, Bank of America raised their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an "underperform" rating in a report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Hold" and a consensus price target of $10.59.
- Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
Read Our Latest Research Report on WBA
About Walgreens Boots Alliance
(Get Free Report)Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Further Reading
- Five stocks we like better than Walgreens Boots Alliance
- Stock Market Upgrades: What Are They?
- Buffett’s Next Oil Bet: Why Occidental Is Different
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Who Led Buybacks to End 2024? Hint: It Wasn’t Big Tech
- There Are Different Types of Stock To Invest In
- Alibaba Caught in Tariff Crossfire: Is It Time to Buy?
- Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Walgreens Boots Alliance Right Now?
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
